| Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism TEPE Investigators N Eng J Med 266, 1287-1297, 2012 | 2929* | 2012 |
| Edoxaban versus Warfarin for the treatment of Symptomatic Venous Thromboembolism THVTE investigators New England Journal of Medicine 369 (15), 1406-1415, 2013 | 2256 | 2013 |
| Apixaban to prevent venous thromboembolism in patients with cancer M Carrier, K Abou-Nassar, R Mallick, V Tagalakis, S Shivakumar, ... New England Journal of Medicine 380 (8), 711-719, 2019 | 854 | 2019 |
| Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. SOX trial investigators. Lancet 383, 880-888, 2014 | 647 | 2014 |
| Thrombosis risk associated with COVID-19 infection. A scoping review F Al-Ani, S Chehade, A Lazo-Langner Thrombosis research 192, 152-160, 2020 | 473 | 2020 |
| Screening for occult cancer in unprovoked venous thromboembolism M Carrier, A Lazo-Langner, S Shivakumar, V Tagalakis, R Zarychanski, ... New England Journal of Medicine 373 (8), 697-704, 2015 | 349 | 2015 |
| Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical Probability C Kearon, K de Wit, S Parpia, S Schulman, M Afilalo, A Hirsch, ... New England Journal of Medicine 381 (22), 2125-2134, 2019 | 336 | 2019 |
| Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism ML Louzada, M Carrier, A Lazo-Langner, V Dao, MJ Kovacs, TO Ramsay, ... Circulation 126 (4), 448-454, 2012 | 259 | 2012 |
| The effect of low‐molecular‐weight heparin on cancer survival. A systematic review and meta‐analysis of randomized trials A Lazo‐Langner, GD Goss, JN Spaans, MA Rodger Journal of Thrombosis and Haemostasis 5 (4), 729-737, 2007 | 251 | 2007 |
| Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update J Bohlius, K Bohlke, R Castelli, B Djulbegovic, MB Lustberg, M Martino, ... Blood advances 3 (8), 1197-1210, 2019 | 220 | 2019 |
| Prothrombin complex concentrate for major bleeding on factor Xa inhibitors: a prospective cohort study S Schulman, PL Gross, B Ritchie, S Nahirniak, Y Lin, L Lieberman, ... Thrombosis and haemostasis 118 (05), 842-851, 2018 | 218 | 2018 |
| A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children BR Del Pozzo-Magana, A Lazo-Langner, B Carleton, LI Castro-Pastrana, ... J Popul Ther Clin Pharmacol 18 (1), 121-33, 2011 | 161 | 2011 |
| Guidance for the management of venous thrombosis in unusual sites W Ageno, J Beyer-Westendorf, DA Garcia, A Lazo-Langner, RD McBane, ... Journal of thrombosis and thrombolysis 41, 129-143, 2016 | 150 | 2016 |
| Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score–matched study M Kang, M Alahmadi, S Sawh, MJ Kovacs, A Lazo-Langner Blood, The Journal of the American Society of Hematology 125 (6), 924-929, 2015 | 144 | 2015 |
| Venous thromboembolism in hospitalized critical and noncritical COVID-19 patients: a systematic review and meta-analysis EM Mansory, S Srigunapalan, A Lazo-Langner TH Open 5 (03), e286-e294, 2021 | 119 | 2021 |
| Long‐term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial MA Rodger, SR Kahn, A Cranney, A Hodsman, MJ Kovacs, AM Clement, ... Journal of Thrombosis and Haemostasis 5 (8), 1600-1606, 2007 | 115 | 2007 |
| Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy IY Gong, RG Tirona, UI Schwarz, N Crown, GK Dresser, S LaRue, ... Blood, The Journal of the American Society of Hematology 118 (11), 3163-3171, 2011 | 113 | 2011 |
| The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta‐analysis of randomized trials D Sanford, A Naidu, N Alizadeh, A Lazo‐Langner Journal of Thrombosis and Haemostasis 12 (7), 1076-1085, 2014 | 105 | 2014 |
| Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiation IY Gong, UI Schwarz, N Crown, GK Dresser, A Lazo-Langner, GY Zou, ... Plos one 6 (11), e27808, 2011 | 102 | 2011 |
| A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2) GA Davies, A Lazo-Langner, E Gandara, M Rodger, V Tagalakis, ... Thrombosis research 162, 88-92, 2018 | 99 | 2018 |
